Exact Sciences Corp (NASDAQ:EXAS) shares are trading lower in Wednesday’s after-hours session on the heels of the company’s first-quarter results. Here’s a rundown of the report. What Happened: Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a quarterly loss of 60 cents per share, which missed analyst estimates for a loss of 48 cents per share. Screening revenue ...